Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.972 EUR | +4.45% | -6.76% | -44.53% |
13/05 | AB Science: European patent granted for masitinib | CF |
03/05 | AB Science: upbeat after legal success | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.53% | 11Cr | |
+16.34% | 7.9TCr | |
+8.65% | 877.86Cr | |
-16.33% | 482.95Cr | |
+51.22% | 465.14Cr | |
+2.18% | 389.22Cr | |
+20.51% | 233.76Cr | |
-26.79% | 217.56Cr | |
+15.12% | 211.24Cr | |
-36.56% | 199.51Cr |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science : Mid-Stage Prostate Cancer Study Meets Primary Endpoint